Cancer Family
Gastric Neoplasm
CI-CAN-00000185Explore in graph →
Non-malignant718 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000185Explore in graph →
Clinical trials
3,260 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01679054 | Cost-minimization Analysis of Gastric Cancer Treatments in Hong Kong | completed | — | 58 | Vivian Wing Yan LeeOTHER | 1 | Mar 12, 2024 | clinicaltrials |
| NCT03619681 | Trial of KN026 in Patients With HER2-positive Advanced Malignant Breast Cancer and Gastric Cancer | completed | Phase 1 | 63 | Jiangsu Alphamab Biopharmaceuticals Co., LtdINDUSTRY | 1 | Mar 12, 2024 | clinicaltrials |
| NCT04834778 | A Study of HC-5404-FU to Establish the Maximum Tolerated Dose (MTD) | completed | Phase 1 | 23 | HiberCell, Inc.INDUSTRY | 1 | Mar 8, 2024 | clinicaltrials |
| NCT06161233 | Pilot Study of the eHealth Application "Cancer Patients Better Life Experience" (CAPABLE) - Italy(CAPABLE-IT) | completed | N/A | 56 | Istituti Clinici Scientifici Maugeri SpAOTHER | 1 | Mar 8, 2024 | clinicaltrials |
| NCT03343301 | A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer(FIGHT) | completed | Phase 1 | 12 | Five Prime Therapeutics, Inc.INDUSTRY | 1 | Feb 28, 2024 | clinicaltrials |
| NCT03694522 | A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer(FIGHT) | completed | Phase 2 | 155 | Five Prime Therapeutics, Inc.INDUSTRY | 18 | Feb 28, 2024 | clinicaltrials |
| NCT03751761 | GC 2nd Line Durvalumab(MEDI4736)/Tremelimumab Plus Paclitaxel Study | completed | Phase 1 / Phase 2 | 58 | Asan Medical CenterOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT06281379 | Complete Mesogastric Excision With D2 Lympadenectomy for Gastric Cancer: | completed | N/A | 37 | Başakşehir Çam & Sakura City HospitalOTHER_GOV | 1 | Feb 28, 2024 | clinicaltrials |
| NCT06282484 | A Study on the Relationship Between Gastric Xanthoma and Gastric Cancer and Precancerous Lesions | completed | — | 1,260 | Xijing Hospital of Digestive DiseasesOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT02830594 | Pembrolizumab and Palliative Radiation Therapy in Treating Patients With Metastatic Esophagus, Stomach, or Gastroesophageal Junction Cancer | completed | Phase 2 | 14 | City of Hope Medical CenterOTHER | 1 | Feb 20, 2024 | clinicaltrials |
| NCT02918162 | Perioperative Chemo and Pembrolizumab in Gastric Cancer | completed | Phase 2 | 49 | Gulam ManjiOTHER | 1 | Feb 15, 2024 | clinicaltrials |
| NCT03990025 | Linked Color Imaging vs White Light Imaging for Detection of Gastric Cancer Precursors | completed | N/A | 90 | Changi General HospitalOTHER | 1 | Feb 15, 2024 | clinicaltrials |
| NCT05083338 | Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative Chemotherapy | completed | — | 24 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 13, 2024 | clinicaltrials |
| NCT03549494 | Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction | completed | Phase 2 | 45 | Catalysis SLINDUSTRY | 1 | Feb 7, 2024 | clinicaltrials |
| NCT04694183 | The Conversion Therapy of Chemotherapy Plus Camrelizumab in Metastatic Gastric Cancer | completed | Phase 2 | 37 | Quan WangOTHER | 1 | Feb 7, 2024 | clinicaltrials |
| NCT03283761 | FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction Adenocarcinoma | completed | Phase 2 | 39 | Al B. Benson, III, MDOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT04074343 | TAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal Adenocarcinoma | completed | Phase 1 | 20 | University of California, IrvineOTHER | 1 | Feb 2, 2024 | clinicaltrials |
| NCT06238752 | First-line Apatinib Combined With Tislelizumab and Chemotherapy for Advanced GC(RENMIN-213) | completed | Phase 2 | 33 | Renmin Hospital of Wuhan UniversityOTHER | 1 | Feb 2, 2024 | clinicaltrials |
| NCT03255070 | A Dose-escalation, Expansion Study of ARX788, in Advanced Solid Tumors Subjects With HER2 Expression (ACE-Pan Tumor 01) | completed | Phase 1 | 106 | Ambrx, Inc.INDUSTRY | 2 | Feb 1, 2024 | clinicaltrials |
| NCT04770623 | Docetaxel and Irinotecan in Gastric Cancer | completed | Phase 2 | 32 | Menoufia UniversityOTHER | 1 | Jan 30, 2024 | clinicaltrials |
| NCT03196232 | Epacadostat and Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Junction or Gastric Cancer | completed | Phase 2 | 3 | George Albert FisherOTHER | 1 | Jan 23, 2024 | clinicaltrials |
| NCT06208046 | Predict 5-Year Survival in Elderly Gastric Cancer | completed | — | 2,187 | Fujian Medical UniversityOTHER | 1 | Jan 17, 2024 | clinicaltrials |
| NCT06205173 | Explored About Temperature Packing Care to Improve the Quality of Life for Chemotherapy Induced Peripheral Neuropathy (CIPN) in Colorectal Cancer and Gastric Cancer Patient | completed | N/A | 18 | National Taiwan University HospitalOTHER | 1 | Jan 12, 2024 | clinicaltrials |
| NCT03472365 | A Study of SHR-1210 in Combination With Capecitabine + Oxaliplatin or Apatinib in Treatment of Advanced Gastric Cancer | completed | Phase 2 | 67 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Jan 11, 2024 | clinicaltrials |
| NCT00486356 | Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer | completed | Phase 1 | 46 | University of NebraskaOTHER | 1 | Jan 3, 2024 | clinicaltrials |
| NCT04686747 | COVID - 19 and Advanced Gastro-intestinal Cancer Treatment(COVID - AGICT) | completed | — | 2,000 | S.M. Misericordia HospitalOTHER | 1 | Jan 3, 2024 | clinicaltrials |
| NCT06185907 | In-hospital Outcomes of Older Patients With Gastric Cancer and Their Risk Factors(GGC-01) | completed | — | 3,238 | Ruijin HospitalOTHER | 1 | Dec 29, 2023 | clinicaltrials |
| NCT05401045 | Effect of a Self-designed MET Exercise Intervention on Cancer-related Fatigue in Patients With Gastric Cancer(SMEE) | completed | N/A | 119 | Ruijin HospitalOTHER | 1 | Dec 21, 2023 | clinicaltrials |
| NCT03783936 | Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas | completed | Phase 2 | 18 | Ashwin SomasundaramOTHER | 1 | Dec 19, 2023 | clinicaltrials |
| NCT03607656 | The Effect of Traditional Chinese Treatment Combined Adjuvant Chemotherapy in IIIb and IIIc Gastric Cancer(CHANGE) | completed | Phase 2 / Phase 3 | 270 | Shanghai University of Traditional Chinese MedicineOTHER | 1 | Dec 18, 2023 | clinicaltrials |
| NCT05606094 | Real-World Observational Study to Describe Treatment Patterns in Patients With HER2-Positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer in East Asia | completed | — | 450 | Daiichi Sankyo Co., Ltd.INDUSTRY | 4 | Dec 15, 2023 | clinicaltrials |
| NCT01515748 | Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric Cancer(PRODIGY) | completed | Phase 3 | 530 | SanofiINDUSTRY | 1 | Dec 13, 2023 | clinicaltrials |
| NCT03618758 | Intraperitoneal Paclitaxel Plus Systemic mFOLFOX6(IPLUS) | completed | Phase 1 / Phase 2 | 35 | Seoul National University Bundang HospitalOTHER | 1 | Dec 5, 2023 | clinicaltrials |
| NCT04227951 | Gastrectomy With or Without Drainage (ADiGe)?(ADiGe) | completed | N/A | 404 | Azienda Ospedaliera Universitaria Integrata VeronaOTHER | 1 | Nov 30, 2023 | clinicaltrials |
| NCT04384575 | Study on the Effectiveness of Gastroscope Operation Quality Control Based on Artificial Intelligence Technology | completed | — | 1,570 | Peking UniversityOTHER | 1 | Nov 29, 2023 | clinicaltrials |
| NCT03568110 | Frailty and Postoperative Outcomes After Gastric Cancer Surgery(TOREGA) | completed | — | 432 | Parc de Salut MarOTHER | 1 | Nov 28, 2023 | clinicaltrials |
| NCT02381249 | The Effect of Satiety Gut Hormone Modulation on Appetitive Drive After Upper Gastrointestinal Surgery | completed | N/A | 40 | St. James's Hospital, IrelandOTHER | 2 | Nov 27, 2023 | clinicaltrials |
| NCT02385617 | Food Intake and Gut Hormones in Patients Who Have Undergone Upper Gastrointestinal Surgery for Cancer | completed | N/A | 20 | St. James's Hospital, IrelandOTHER | 2 | Nov 27, 2023 | clinicaltrials |
| NCT02599324 | Study to Evaluate Ibrutinib Combination Therapy in Patients With Selected Gastrointestinal and Genitourinary Tumors | completed | Phase 1 / Phase 2 | 263 | Pharmacyclics LLC.INDUSTRY | 4 | Nov 18, 2023 | clinicaltrials |
| NCT02178956 | A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer(BRIGHTER) | completed | Phase 3 | 714 | Sumitomo Pharma America, Inc.INDUSTRY | 22 | Nov 15, 2023 | clinicaltrials |
| NCT02624271 | Diagnosis of Gastric Precancerous Lesions by a Blood Test GastroPanel in Patients With Increased Gastric Cancer Risk(GASTRO-PRA) | completed | N/A | 2,000 | Nantes University HospitalOTHER | 1 | Nov 15, 2023 | clinicaltrials |
| NCT05400915 | Two-Part, Phase Ib/II, Open Label, Single-Arm, Multi-center Study to Evaluate the Safety and Efficacy of Varlitinib in Combination With Weekly Paclitaxel in EGFR/HER2 Co-expressing Advanced or Metastatic Gastric Cancer Patients | completed | Phase 1 / Phase 2 | 27 | Yonsei UniversityOTHER | 1 | Nov 13, 2023 | clinicaltrials |
| NCT03304210 | PIPAC Nab-pac for Stomach, Pancreas, Breast and Ovarian Cancer(PIPAC-nabpac) | completed | Phase 1 | 20 | University Hospital, GhentOTHER | 1 | Nov 7, 2023 | clinicaltrials |
| NCT01522768 | Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer | completed | Phase 2 | 42 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 1, 2023 | clinicaltrials |
| NCT06103435 | Multivisceral Resections for Locally Advanced Gastric Cancer(TOCCATA) | completed | — | 1,476 | Jagiellonian UniversityOTHER | 1 | Oct 26, 2023 | clinicaltrials |
| NCT01401907 | Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies | completed | N/A | 351 | Massachusetts General HospitalOTHER | 1 | Oct 19, 2023 | clinicaltrials |
| NCT02555358 | Three Drugs in Advanced Gastric Cancer Neoadjuvant Chemotherapy for Stage Ⅲ Clinical Study | completed | Phase 2 | 300 | Qun ZhaoOTHER | 1 | Oct 19, 2023 | clinicaltrials |
| NCT03756597 | PAN-study: Pan-Cancer Early Detection Study (PAN) | completed | — | 268 | Owlstone LtdINDUSTRY | 1 | Oct 5, 2023 | clinicaltrials |
| NCT02337673 | Screening of Postoperative Pulmonary Complications by Electrical Impedance Tomography | completed | — | 130 | Johannes Gutenberg University MainzOTHER | 1 | Sep 29, 2023 | clinicaltrials |
| NCT04188990 | Cost Effectiveness of an Intervention in Hospitalized Patients With Disease-related Malnutrition | completed | N/A | 1,051 | Hospital Galdakao-UsansoloOTHER_GOV | 1 | Sep 21, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Mar 12, 2024source: clinicaltrials